R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 61.14
-2.51 (-3.94%)
Oct 13, 2026, 4:00 PM EDT
R&G PharmaStudies Market Cap
R&G PharmaStudies has a market cap or net worth of 5.86 billion as of October 13, 2026. It is the 10,734th most valuable company in the world and the 2,525th biggest in China. Its market cap has increased by 17.08% in one year.
Market Cap
5.86B
Enterprise Value
4.21B
Revenue
939.31M
Global Rank
Country Rank
#2,525 China
PE Ratio
48.97
ChartMarket Cap Chart
Since August 2, 2022, R&G PharmaStudies's market cap has increased from 5.40B to 5.86B, an increase of 8.45%. That is a compound annual growth rate of 1.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 5.86B | 3.38% |
| Dec 31, 2025 | 5.67B | 19.12% |
| Dec 31, 2024 | 4.76B | -23.17% |
| Dec 29, 2023 | 6.19B | 25.30% |
| Dec 30, 2022 | 4.94B | -8.52% |
| Aug 2, 2022 | 5.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovita Biological Technology | 7.02B |
| Beijing Hotgen Biotech | 6.88B |
| Chengdu Kanghua Biological Products | 6.82B |
| Zhejiang Ausun Pharmaceutical | 6.50B |
| PharmaResources (Shanghai) | 6.29B |
| Jiangsu Aidea Pharmaceutical Group | 6.02B |
| Hangzhou Biotest Biotech | 5.71B |
| Youcare Pharmaceutical Group | 5.66B |